Advertisement
Screener

VERU INC. (VERU) Number of Operating Segments

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Number of Operating Segments

VERU INC. (VERU) reported Number of Operating Segments of 100.00% for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfOperatingSegments · last filed 2026-08-10

  • VERU INC. number of operating segments for the quarter ending 2026-03-31 was 100.00%.
  • VERU INC. number of operating segments for the quarter ending 2025-12-31 was 100.00%.
  • VERU INC. number of operating segments for the quarter ending 2013-03-31 was 100.00%.
  • VERU INC. number of operating segments for the quarter ending 2012-12-31 was 100.00%.
  • VERU INC. number of operating segments for fiscal 2025 was 100.00%, a 0.00% change from fiscal 2024.
  • VERU INC. number of operating segments for fiscal 2024 was 100.00%.

pure

Period endNumber of Operating Segments 3 monthNumber of Operating Segments 9 monthNumber of Operating Segments 12 month
2026-06-30100.00%
10-Q · filed 2026-08-10
2026-03-31100.00%
10-Q · filed 2026-05-13
2025-12-31100.00%
10-Q · filed 2026-02-11
2025-09-30100.00%
10-K · filed 2025-12-17
2024-09-30100.00%
10-K · filed 2024-12-16
2013-06-30100.00%
10-Q · filed 2013-08-01
2013-03-31100.00%
10-Q · filed 2013-05-02
2012-12-31100.00%
10-Q · filed 2013-01-30
2012-06-30100.00%
10-Q · filed 2012-07-31

segment

Period endNumber of Operating Segments 3 monthNumber of Operating Segments 6 monthNumber of Operating Segments 9 monthNumber of Operating Segments 12 month
2023-09-301.00 segment
10-K/A · filed 2024-04-01
2022-09-301.00 segment
10-K · filed 2022-12-05
2022-06-301.00 segment
10-Q · filed 2022-08-11
2022-03-311.00 segment
10-Q · filed 2022-05-12
2021-12-312.00 segment
10-Q · filed 2022-08-11
2021-09-302.00 segment
10-K · filed 2021-12-02
2020-12-312.00 segment
10-Q · filed 2022-02-09
2016-06-301.00 segment
10-Q · filed 2016-07-28
2016-03-311.00 segment
10-Q · filed 2016-04-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34